Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999281 · ClinicalTrials.gov registry record
Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU
A clinical trial, sponsored by Solsys Medical.
- Completed
- Registry status
- 188
- Enrollment target
NCT03999281: Completed study, sponsored by Solsys Medical.
NCT03999281 is a clinical trial that has completed, run by Solsys Medical. The registered enrollment target is 188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03999281 has completed, sponsored by Solsys Medical.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
Retrospective clinical study of 188 patients to examine effectiveness of human cryopreserved allograft in the treatment of diabetic foot ulcers and venous leg ulcers
Primary Outcome
Theraskin used together with standard of care in healing DFU and VLU wounds
Interventions
- OTHER Human Allograft (Theraskin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2003-03-20 |
| Est. Completion | 2009-09-20 |
What the finished NCT03999281 record still lists
NCT03999281 is an observational study that tracks outcomes without assigning an intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Human Allograft (Theraskin) is the first listed.
NCT03999281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03999281 about?
NCT03999281 is a clinical study titled "Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU". Retrospective clinical study of 188 patients to examine effectiveness of human cryopreserved allograft in the treatment of diabetic foot ulcers and venous leg ulcers
What is the current status of trial NCT03999281?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2003-03-20. Estimated completion is 2009-09-20.
What interventions are being tested in trial NCT03999281?
The interventions under investigation include: Human Allograft (Theraskin) (OTHER).
Who is sponsoring clinical trial NCT03999281?
This trial is sponsored by Solsys Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI